Financial statements Arno-Bio
Balance sheet data of ARNO-BIO
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 449 586,99 | 5 414 997,65 | 5 394 214,81 | 5 375 667,59 | 5 375 667,59 | 5 375 667,59 |
| A. Fixed assets | 5 340 744,23 | 5 319 926,39 | 5 299 108,55 | 5 280 561,33 | 5 280 561,33 | 5 280 561,33 |
| B. Current assets | 108 842,76 | 95 071,26 | 95 106,26 | 95 106,26 | 95 106,26 | 95 106,26 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 5 449 586,99 | 5 414 997,65 | 5 394 214,81 | 5 375 667,59 | 5 375 667,59 | 5 375 667,59 |
| A. Equity | -8 271 063,63 | -8 708 831,99 | -9 188 283,82 | -9 665 131,03 | -10 123 431,02 | -10 581 731,01 |
| B. Liabilities and provisions for liabilities | 13 720 650,62 | 14 123 829,64 | 14 582 498,63 | 15 040 798,62 | 15 499 098,61 | 15 957 398,60 |
| I. Long-term liabilities | 11 275 027,42 | 11 733 327,41 | 12 191 627,40 | 12 649 927,39 | 13 108 227,38 | 13 566 527,37 |
| II. Short-term liabilities | 2 445 623,20 | 2 390 502,23 | 2 390 871,23 | 2 390 871,23 | 2 390 871,23 | 2 390 871,23 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.